Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis

Liu GE;Cai W;Liu H;Jiang HH;Yi Bi Y;Wang H;;
Turkish journal of medical sciences 2021 pp. -
101
ge2021turkishmalignancy

Abstract

Malignancy was associated with up to 2.3-fold higher risk of severe/critical COVID-19 and may serve as a clinical predictor for adverse outcomes.

Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34022777 doi:10.3906/sag-2101-192 G E Liu Wei Cai Hong Wang

Access

URL:
http://www.ncbi.nlm.nih.gov/pubmed/34022777

Citation

ID: 269439
Ref Key: ge2021turkishmalignancy
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
269439
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store